Skip to content

Advertisement

Open Peer Review Reports for: Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
4 Jan 2017 Submitted Original manuscript
21 Feb 2017 Reviewed Reviewer Report - Robert Moss
23 Feb 2017 Reviewed Reviewer Report - Wendong Liu
24 Mar 2017 Author responded Author comments - Teresa Kauf
Resubmission - Version 2
24 Mar 2017 Submitted Manuscript version 2
13 Apr 2017 Author responded Author comments - Teresa Kauf
Resubmission - Version 3
13 Apr 2017 Submitted Manuscript version 3
Publishing
18 Apr 2017 Editorially accepted
28 Apr 2017 Article published 10.1186/s12879-017-2408-7

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement